2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Objective
The 1980 American College of Rheumatology (ACR) classification criteria for systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present work, by a joint committee of the ACR and the European League Against Rheumatism (EULAR), was undertaken for the purpose of developing new classification criteria for SSc.
Methods
Using consensus methods, 23 candidate items were arranged in a multicriteria additive point system with a threshold to classify cases as SSc. The classification system was reduced by clustering items and simplifying weights. The system was tested by (1) determining specificity and sensitivity in SSc cases and controls with scleroderma-like disorders, and (2) validating against the combined view of a group of experts on a set of cases with or without SSc.
Results
It was determined that skin thickening of the fingers extending proximal to the metacarpophalangeal joints is sufficient for the patient to be classified as having SSc; if that is not present, seven additive items apply, with varying weights for each: skin thickening of the fingers, fingertip lesions, telangiectasia, abnormal nailfold capillaries, interstitial lung disease or pulmonary arterial hypertension, Raynaud9s phenomenon, and SSc-related autoantibodies. Sensitivity and specificity in the validation sample were, respectively, 0.91 and 0.92 for the new classification criteria and 0.75 and 0.72 for the 1980 ACR classification criteria. All selected cases were classified in accordance with consensus-based expert opinion. All cases classified as SSc according to the 1980 ACR criteria were classified as SSc with the new criteria, and several additional cases were now considered to be SSc.
Conclusions
The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria for SSc and should allow for more patients to be classified correctly as having the disease.
Top-30
Journals
|
20
40
60
80
100
120
140
160
180
|
|
|
Rheumatology
164 publications, 8.17%
|
|
|
Clinical Rheumatology
76 publications, 3.78%
|
|
|
Arthritis Research and Therapy
65 publications, 3.24%
|
|
|
Annals of the Rheumatic Diseases
60 publications, 2.99%
|
|
|
Journal of Scleroderma and Related Disorders
59 publications, 2.94%
|
|
|
Rheumatology International
47 publications, 2.34%
|
|
|
Frontiers in Immunology
42 publications, 2.09%
|
|
|
RMD Open
42 publications, 2.09%
|
|
|
Scientific Reports
35 publications, 1.74%
|
|
|
Seminars in Arthritis and Rheumatism
35 publications, 1.74%
|
|
|
Autoimmunity Reviews
31 publications, 1.54%
|
|
|
International Journal of Rheumatic Diseases
30 publications, 1.49%
|
|
|
Journal of Clinical Medicine
27 publications, 1.34%
|
|
|
Journal of Rheumatology
26 publications, 1.29%
|
|
|
Microvascular Research
26 publications, 1.29%
|
|
|
Diagnostics
23 publications, 1.15%
|
|
|
International Journal of Molecular Sciences
23 publications, 1.15%
|
|
|
Arthritis Care and Research
20 publications, 1%
|
|
|
Egyptian Rheumatologist
18 publications, 0.9%
|
|
|
Journal of Dermatology
18 publications, 0.9%
|
|
|
PLoS ONE
17 publications, 0.85%
|
|
|
Modern Rheumatology
17 publications, 0.85%
|
|
|
Frontiers in Medicine
16 publications, 0.8%
|
|
|
Journal of Autoimmunity
16 publications, 0.8%
|
|
|
Arthritis and Rheumatology
16 publications, 0.8%
|
|
|
The Lancet Rheumatology
15 publications, 0.75%
|
|
|
Best Practice and Research in Clinical Rheumatology
15 publications, 0.75%
|
|
|
Scandinavian Journal of Rheumatology
15 publications, 0.75%
|
|
|
Current Opinion in Rheumatology
14 publications, 0.7%
|
|
|
20
40
60
80
100
120
140
160
180
|
Publishers
|
50
100
150
200
250
300
350
400
450
500
|
|
|
Elsevier
470 publications, 23.41%
|
|
|
Springer Nature
414 publications, 20.62%
|
|
|
Oxford University Press
186 publications, 9.26%
|
|
|
Wiley
175 publications, 8.72%
|
|
|
MDPI
127 publications, 6.32%
|
|
|
SAGE
86 publications, 4.28%
|
|
|
Frontiers Media S.A.
76 publications, 3.78%
|
|
|
Taylor & Francis
68 publications, 3.39%
|
|
|
BMJ
60 publications, 2.99%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
46 publications, 2.29%
|
|
|
The Journal of Rheumatology
26 publications, 1.29%
|
|
|
Hindawi Limited
22 publications, 1.1%
|
|
|
Cold Spring Harbor Laboratory
21 publications, 1.05%
|
|
|
Public Library of Science (PLoS)
17 publications, 0.85%
|
|
|
Georg Thieme Verlag KG
15 publications, 0.75%
|
|
|
The Egyptian Society for Joint Diseases and Arthritis
13 publications, 0.65%
|
|
|
Mediar Press
10 publications, 0.5%
|
|
|
S. Karger AG
9 publications, 0.45%
|
|
|
AME Publishing Company
9 publications, 0.45%
|
|
|
Bentham Science Publishers Ltd.
8 publications, 0.4%
|
|
|
American Thoracic Society
7 publications, 0.35%
|
|
|
European Respiratory Society (ERS)
7 publications, 0.35%
|
|
|
Spandidos Publications
4 publications, 0.2%
|
|
|
Asociacion Colombiana de Reumatologia
4 publications, 0.2%
|
|
|
Termedia Sp. z.o.o.
4 publications, 0.2%
|
|
|
IMA Press, LLC
4 publications, 0.2%
|
|
|
JMIR Publications
3 publications, 0.15%
|
|
|
American Medical Association (AMA)
3 publications, 0.15%
|
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 0.15%
|
|
|
50
100
150
200
250
300
350
400
450
500
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.